← FDA Drug Approvals (Drugs@FDA)

LIDOCAINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: IBSA · Approved 2020-04-30

Drug application

FDA Application #

ANDA209190

Application type

Abbreviated New Drug Application (Generic)

Brand name

LIDOCAINE

Generic name

LIDOCAINE 5%

Active ingredients

LIDOCAINE

Dosage form

PATCH

Route

TOPICAL

Marketing status

Prescription

Sponsor

IBSA

Manufacturer

PURETEK CORPORATION

First approval

2020-04-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown